Ropp Sam 4
4 · Singular Genomics Systems, Inc. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Ropp Sam
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-15+4,187→ 16,750 total - Exercise/Conversion
Restricted Stock Units
2024-03-15−4,187→ 50,250 total→ Common Stock (4,187 underlying)
Footnotes (3)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.